NOVIGENIX ^None

Novigenix is a Swiss precision medicine company that focuses on ImmunoTranscriptomic solutions for disease detection, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes. The company uses its proprietary LITOseek platform to map the immune system's response to disease and provide precision solutions for patient treatment. Novigenix's product pipeline includes patient stratification solutions in Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and therapy optimization solutions for cancer patients. The company provides services to Pharma and Biotech customers by leveraging its proprietary LITOseek data analytics and patient clinical data platform to develop ImmunoTranscriptomic solutions with actionable biomarkers for optimization of new therapeutic modalities.